LLY compared with TPST: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

TPSTTempest Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

TPSTTempest Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

TPST1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−13.25%—

= impliedLLY realized, solidTPST realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,419.27

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

TPSTTempest Therapeutics, Inc.

0.46▼−2.26%· post 0.46

ClosedNov 4 '26

Mkt cap$6.9MRevenue—Revenue—

Compare

ClosedNov 4 '26

LLYELI Lilly & Co

TPSTTempest Therapeutics, Inc.

1,417.89▲+0.60%post 1,419.27

Price

0.46▼−2.26%post 0.46

$1.3T

Mkt cap

$6.9M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,417.89▲+0.60%vsTPST0.46▼−2.26%ClosedNov 4 '26